ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

In Brief; Jerome Green To Head NIH Div. Of Research Grants; M.D. Anderson’s Even Hersh To Join Univ. of Arizona

December 13, 1985

New ACS Structure Proposed, approved

August 6, 1993

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010

I-ELCAP Leaders Named as Inventors on 27 Patents; Journals Probe Disclosures.

January 18, 2008

In Brief: Cancer Act Extension, Training Bill Breezing Through Congress; Army Causes Ft. Detrick Flap

July 5, 1974